KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Supernus Pharmaceuticals (SUPN) Tax Rate (2016 - 2025)

Supernus Pharmaceuticals has reported Tax Rate over the past 12 years, most recently at 114.47% for Q4 2025.

  • Quarterly Tax Rate fell 15637.0% to 114.47% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 21.31% through Dec 2025, down 322.0% year-over-year, with the annual reading at 21.37% for FY2025, 315.0% down from the prior year.
  • Tax Rate was 114.47% for Q4 2025 at Supernus Pharmaceuticals, down from 22.15% in the prior quarter.
  • Over five years, Tax Rate peaked at 493.92% in Q3 2022 and troughed at 114.47% in Q4 2025.
  • The 5-year median for Tax Rate is 24.19% (2024), against an average of 34.94%.
  • Year-over-year, Tax Rate soared 46837bps in 2022 and then crashed -24756bps in 2024.
  • A 5-year view of Tax Rate shows it stood at 19.06% in 2021, then skyrocketed by 244bps to 27.41% in 2022, then tumbled by -168bps to 18.69% in 2023, then skyrocketed by 324bps to 41.9% in 2024, then crashed by -373bps to 114.47% in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Tax Rate are 114.47% (Q4 2025), 22.15% (Q3 2025), and 34.8% (Q2 2025).